bupropion hydrochloride
Generic: bupropion hydrochloride
Labeler: amneal pharmaceuticals of new york llcDrug Facts
Product Profile
Brand Name
bupropion hydrochloride
Generic Name
bupropion hydrochloride
Labeler
amneal pharmaceuticals of new york llc
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Routes
Active Ingredients
bupropion hydrochloride 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0115-5445
Product ID
0115-5445_cb660c34-cfd0-4598-a767-db8a82e087e0
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA076711
Listing Expiration
2026-12-31
Marketing Start
2004-12-03
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
01155445
Hyphenated Format
0115-5445
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
bupropion hydrochloride (source: ndc)
Generic Name
bupropion hydrochloride (source: ndc)
Application Number
ANDA076711 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-5445-13)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "cb660c34-cfd0-4598-a767-db8a82e087e0", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993536"], "spl_set_id": ["e962fb9a-d9fb-49c5-a8b4-0b355b8f829b"], "manufacturer_name": ["Amneal Pharmaceuticals of New York LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-5445-13)", "package_ndc": "0115-5445-13", "marketing_start_date": "20041203"}], "brand_name": "Bupropion Hydrochloride", "product_id": "0115-5445_cb660c34-cfd0-4598-a767-db8a82e087e0", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0115-5445", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Amneal Pharmaceuticals of New York LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "200 mg/1"}], "application_number": "ANDA076711", "marketing_category": "ANDA", "marketing_start_date": "20041203", "listing_expiration_date": "20261231"}